Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and a major cause of several cancers, including cervical, oropharyngeal, anal, vaginal, vulvar, and penile cancers.1 Globally, HPV accounts for approximately 620,000 cancer cases in women and 70,000 cases in men each year. In Vietnam, cervical cancer is the fifth most common cancer among women of reproductive age, with around 4,600 new cases and 2,600 deaths annually, and HPV-related cancers are increasingly recognized among men. HPV vaccination is one of the most effective strategies to prevent HPV infection and related cancers. In 2024, the Vietnamese government announced plans to introduce the HPV vaccine into the National Expanded Program on Immunization starting in 2026; however, vaccine uptake may vary following national rollout. Given limited contemporary evidence on parental perspectives toward HPV vaccination in Vietnam, this study aims to generate timely, parent-centered data to inform vaccine implementation and communication efforts.
The objective is to increase HPV vaccine confidence and uptake in Vietnamese adolescent girls eligible for HPV vaccination, thereby reducing HPV-related cancer incidence and mortality.
Principal Investigator and Co-Principal Investigators:
Pham Thanh Tung, College of Health Sciences, VinUniversity, Vietnam
Ha Ngan Vu, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, US
Bui Phuong Linh, College of Health Sciences, VinUniversity, Vietnam
Members:
Truong Thi Anh Nguyet, College of Health Sciences, VinUniversity, Vietnam
Ho Hoang Dung, College of Health Sciences, VinUniversity, Vietnam
Giang Huyen Anh, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, US
This study was funded by the READS Grant of the American Association for Cancer Education (AACE) in 2026.